KNOW WHAT TO EXPECT

BEFORE YOU SELECT A CRO FOR YOUR RARE DISEASE STUDY

Find out what other sponsors say about working with Worldwide.

Industry Standard Research asked biopharma and pharmaceutical executives from North America, Europe, and Asia to rate more than three dozen Phase II-III CRO providers on staff, delivery, budget, loyalty, and more.*

WORLDWIDE’S STAFF OUTPERFORMED ALL COMPETITORS IN TERMS OF PROJECT MANAGER QUALITY, RESPONSIVENESS, AND TIMELY PROJECT COMMUNICATIONS. THAT’S WHY WE’RE THE #1 OVERALL CRO AND A LEADER IN CUSTOMER LOYALTY.

WORLDWIDE OUTPERFORMED OTHER CROS IN:

DELIVERY FACTORS:

Data quality

Easy to work with

Operational excellence

Patient/volunteer recruitment

Technology for real-time access to data

STAFF CHARACTERISTICS:

Project manager quality

Responsiveness

Study design expertise

Timely project communications

BUDGET FACTORS:

Appropriateness of change orders

Cost

READ FULL REPORT

DOWNLOAD FULL REPORT

Get The Executive Summary

Fill out the brief form to take a fact-based approach to choosing your clinical development partner with the 2021 ISR Reports.

LET'S PARTNER ON YOUR RARE DISEASE STUDY

Rare and orphan disease clinical research requires experienced teams to address the inevitable obstacles in their development programs. That’s why you need a knowledgeable partner with responsive delivery.

Worldwide combines deep scientific expertise with fresh perspectives on design and patient outreach—we are experts with decades of experience and a drive to innovate and find unique solutions for your rare disease program. We are agile in our approach, pivoting quickly to address challenges with informed decisions.

As your rare disease development partner, you can trust Worldwide has the resources and commitment to help you succeed.

Rare Disease Experience

Autoimmune and Inflammation
Blood Disorders
Disorders of the Heart, Lungs, and Kidneys
Endocrine and Metabolic Disorders
Eye Disorders

Genetic Disorders
Musculoskeletal Disorders
Nervous System Disorders
Rare Cancers

WE WANT TO WORK WITH YOU

Fill out the form to discuss your rare disease needs with us.

*RATING METHODOLOGY

As rated by customers for Phase II-III CRO services. Respondents were required to pass several screening criteria to qualify and participate in this survey:

Must work at a pharmaceutical company, biotech company, or medical device company
Must have responsibility in at least one of several relevant areas such as Clinical Operations, Project Management, Executive Management, or Research and Development Management
Must have involvement with outsourced Phase II-III trials within past 12 months